ATE443867T1 - Methode zur vorhersage der sepsis in einem patienten mit systemischem inflammatorischem response-syndrom (sirs) - Google Patents

Methode zur vorhersage der sepsis in einem patienten mit systemischem inflammatorischem response-syndrom (sirs)

Info

Publication number
ATE443867T1
ATE443867T1 AT03746054T AT03746054T ATE443867T1 AT E443867 T1 ATE443867 T1 AT E443867T1 AT 03746054 T AT03746054 T AT 03746054T AT 03746054 T AT03746054 T AT 03746054T AT E443867 T1 ATE443867 T1 AT E443867T1
Authority
AT
Austria
Prior art keywords
inflammatory response
sirs
patient
systemic inflammatory
response syndrome
Prior art date
Application number
AT03746054T
Other languages
English (en)
Inventor
Stephen Anderson
Douglas J Haney
Cory Waters
Original Assignee
Becton Dickinson Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Becton Dickinson Co filed Critical Becton Dickinson Co
Application granted granted Critical
Publication of ATE443867T1 publication Critical patent/ATE443867T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G01N2333/70535—Fc-receptors, e.g. CD16, CD32, CD64 (CD2314/705F)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70546—Integrin superfamily, e.g. VLAs, leuCAM, GPIIb/GPIIIa, LPAM
    • G01N2333/70553—Integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70596—Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/26—Infectious diseases, e.g. generalised sepsis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT03746054T 2002-04-02 2003-03-27 Methode zur vorhersage der sepsis in einem patienten mit systemischem inflammatorischem response-syndrom (sirs) ATE443867T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37011502P 2002-04-02 2002-04-02
PCT/US2003/009351 WO2003084388A2 (en) 2002-04-02 2003-03-27 Early detection of sepsis

Publications (1)

Publication Number Publication Date
ATE443867T1 true ATE443867T1 (de) 2009-10-15

Family

ID=28792031

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03746054T ATE443867T1 (de) 2002-04-02 2003-03-27 Methode zur vorhersage der sepsis in einem patienten mit systemischem inflammatorischem response-syndrom (sirs)

Country Status (6)

Country Link
US (1) US7465555B2 (de)
EP (1) EP1490789B1 (de)
JP (1) JP4520157B2 (de)
AT (1) ATE443867T1 (de)
DE (1) DE60329377D1 (de)
WO (1) WO2003084388A2 (de)

Families Citing this family (104)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9042952B2 (en) 1997-01-27 2015-05-26 Lawrence A. Lynn System and method for automatic detection of a plurality of SPO2 time series pattern types
US20060161071A1 (en) 1997-01-27 2006-07-20 Lynn Lawrence A Time series objectification system and method
US8932227B2 (en) 2000-07-28 2015-01-13 Lawrence A. Lynn System and method for CO2 and oximetry integration
US9521971B2 (en) 1997-07-14 2016-12-20 Lawrence A. Lynn System and method for automatic detection of a plurality of SPO2 time series pattern types
US20070191697A1 (en) 2006-02-10 2007-08-16 Lynn Lawrence A System and method for SPO2 instability detection and quantification
US7184963B1 (en) * 1999-01-19 2007-02-27 Bristol-Myers Squibb Company Method for determining care and prevention pathways for clinical management of wounds
US8914114B2 (en) 2000-05-23 2014-12-16 The Feinstein Institute For Medical Research Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
US9053222B2 (en) 2002-05-17 2015-06-09 Lawrence A. Lynn Patient safety processor
US20060195041A1 (en) 2002-05-17 2006-08-31 Lynn Lawrence A Centralized hospital monitoring system for automatically detecting upper airway instability and for preventing and aborting adverse drug reactions
US7465555B2 (en) * 2002-04-02 2008-12-16 Becton, Dickinson And Company Early detection of sepsis
US20050288571A1 (en) * 2002-08-20 2005-12-29 Welch Allyn, Inc. Mobile medical workstation
EP1573054A4 (de) * 2002-11-12 2005-12-28 Becton Dickinson Co Sepsis- oder sirs-diagnose mittels biomarkerprofilen
MXPA05005031A (es) * 2002-11-12 2005-11-17 Becton Dickinson Co Diagnostico de la sepsis o sirs usando perfiles de biomarcadores.
EP1590469A4 (de) * 2002-11-12 2005-12-28 Becton Dickinson Co Sepsis- oder sirs-diagnose mittels biomarkerprofilen
WO2004087949A2 (de) * 2003-04-02 2004-10-14 Sirs-Lab Gmbh Verfahren zur erkennung akuter generalisierter entzündlicher zustände (sirs), sepsis, sepsisähnlichen zuständen und systemischen infektionen
WO2005048823A2 (en) * 2003-11-17 2005-06-02 Janssen Pharmaceutica N.V. Modeling of systemic inflammatory response to infection
DK1708690T3 (en) 2003-11-17 2016-11-07 Biomarin Pharm Inc TREATMENT OF PHENYLKETONURI WITH BH4
DE102004009952B4 (de) * 2004-03-01 2011-06-01 Sirs-Lab Gmbh Verfahren zur Erkennung von Sepsis
US10912712B2 (en) 2004-03-25 2021-02-09 The Feinstein Institutes For Medical Research Treatment of bleeding by non-invasive stimulation
AU2005225458B2 (en) 2004-03-25 2008-12-04 The Feinstein Institutes For Medical Research Neural tourniquet
DE102004015605B4 (de) * 2004-03-30 2012-04-26 Sirs-Lab Gmbh Verfahren zur Vorhersage des individuellen Krankheitsverlaufs bei Sepsis
DE102004049897B4 (de) * 2004-10-13 2007-11-22 Sirs-Lab Gmbh Verfahren zur Unterscheidung zwischen nichtinfektiösen und infektiösen Ursachen eines Multiorganversagens
EP1836557A4 (de) 2004-11-19 2009-01-21 Trillium Diagnostics Llc Softwareintegrierter durchflusszytometrietest zur quantifizierung des menschlichen polymorphkernigen leukozyt-fc-ri-rezeptors (cd64)
CN101124012B (zh) 2004-12-27 2012-09-05 范因斯坦医学研究院 通过电刺激迷走神经治疗炎症性疾病的装置
US11207518B2 (en) 2004-12-27 2021-12-28 The Feinstein Institutes For Medical Research Treating inflammatory disorders by stimulation of the cholinergic anti-inflammatory pathway
US20060157647A1 (en) * 2005-01-18 2006-07-20 Becton, Dickinson And Company Multidimensional liquid chromatography/spectrometry
DE102005013013A1 (de) * 2005-03-21 2006-09-28 Sirs-Lab Gmbh Verwendung von Genaktivitäts-Klassifikatoren für die in vitro Klassifizierung von Genexpressionsprofilen von Patienten mit infektiösem/nichtinfektiösem Multiorganversagen
KR20080006617A (ko) 2005-04-15 2008-01-16 백톤 디킨슨 앤드 컴퍼니 패혈증의 진단
EP1910565A4 (de) * 2005-07-07 2009-10-28 Athlomics Pty Ltd Polynukleotidmarkergene und deren expression zur diagnose von endotoxämie
EP1904941A4 (de) * 2005-07-18 2009-10-21 Integralis Ltd Vorrichtung, verfahren und computerlesbarer code zur vorhersage des aufkommens einer potentiell lebensgefährlichen krankheit
AU2006294481B2 (en) 2005-09-28 2012-12-20 Becton, Dickinson And Company Detection of lysophosphatidylcholine for prognosis or diagnosis of a systemic inflammatory condition
DE102005050933A1 (de) * 2005-10-21 2007-04-26 Justus-Liebig-Universität Giessen Erfindung betreffend Expressionsprofile zur Vorhersage von septischen Zuständen
US7668579B2 (en) 2006-02-10 2010-02-23 Lynn Lawrence A System and method for the detection of physiologic response to stimulation
CA2651110A1 (en) * 2006-05-02 2007-11-08 Therakos, Inc. Methods and reagents for detecting susceptibility to graft versus host disease or transplant related mortality
GB0610078D0 (en) * 2006-05-20 2006-06-28 Secr Defence Sepsis detection microarray
US20090104605A1 (en) * 2006-12-14 2009-04-23 Gary Siuzdak Diagnosis of sepsis
US8221995B2 (en) 2007-03-23 2012-07-17 Seok-Won Lee Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes
US7611483B2 (en) * 2007-04-19 2009-11-03 Medtronic, Inc. Indicator metrics for infection monitoring
US20080262331A1 (en) * 2007-04-19 2008-10-23 Medtronic, Inc. Infection monitoring
US7682355B2 (en) * 2007-04-19 2010-03-23 Medtronic, Inc. Refined infection monitoring
US7734353B2 (en) 2007-04-19 2010-06-08 Medtronic Inc. Controlling temperature during recharge for treatment of infection or other conditions
US20080262374A1 (en) * 2007-04-19 2008-10-23 Medtronic, Inc. Event triggered infection monitoring
US20100279878A1 (en) * 2007-05-14 2010-11-04 Wong Hector R Biomarkers for Septic Shock Patients
JP5357871B2 (ja) * 2007-07-13 2013-12-04 コーニンクレッカ フィリップス エヌ ヴェ 急性の動的な疾患の意思決定支援システム
WO2009029614A1 (en) * 2007-08-27 2009-03-05 The Feinstein Institute For Medical Research Devices and methods for inhibiting granulocyte activation by neural stimulation
WO2009033050A1 (en) * 2007-09-07 2009-03-12 University Of Pittsburgh-Of The Commonwealth Sys Tem Of Higher Education Diagnostic and therapeutic uses of augmenter of liver regeneration in inflammatory conditions
GB0722729D0 (en) * 2007-11-20 2007-12-27 Bristol Myers Squibb Co Diagnostic markers of wound infection
DE102008000715B9 (de) 2008-03-17 2013-01-17 Sirs-Lab Gmbh Verfahren zur in vitro Erfasssung und Unterscheidung von pathophysiologischen Zuständen
AU2013231105B2 (en) * 2008-03-26 2016-07-07 Theranos Ip Company, Llc Methods and systems for assessing clinical outcomes
CN106126881A (zh) * 2008-03-26 2016-11-16 赛拉诺斯股份有限公司 表征对象的临床结果的计算机系统
US9662490B2 (en) 2008-03-31 2017-05-30 The Feinstein Institute For Medical Research Methods and systems for reducing inflammation by neuromodulation and administration of an anti-inflammatory drug
WO2009146030A1 (en) 2008-03-31 2009-12-03 The Feinstein Institute For Medical Research Methods and systems for reducing inflammation by neuromodulation of t-cell activity
US8669113B2 (en) 2008-04-03 2014-03-11 Becton, Dickinson And Company Advanced detection of sepsis
JP5474937B2 (ja) * 2008-05-07 2014-04-16 ローレンス エー． リン， 医療障害パターン検索エンジン
US11728041B2 (en) 2008-05-07 2023-08-15 Lawrence A. Lynn Real-time time series matrix pathophysiologic pattern processor and quality assessment method
US8380531B2 (en) * 2008-07-25 2013-02-19 Invivodata, Inc. Clinical trial endpoint development process
WO2010041232A2 (en) * 2008-10-09 2010-04-15 The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth, Near Dublin A method of estimating sepsis risk in an individual with infection
WO2010059617A2 (en) 2008-11-18 2010-05-27 Setpoint Medical Corporation Devices and methods for optimizing electrode placement for anti-inflamatory stimulation
US8886339B2 (en) 2009-06-09 2014-11-11 Setpoint Medical Corporation Nerve cuff with pocket for leadless stimulator
US8996116B2 (en) 2009-10-30 2015-03-31 Setpoint Medical Corporation Modulation of the cholinergic anti-inflammatory pathway to treat pain or addiction
US9211410B2 (en) 2009-05-01 2015-12-15 Setpoint Medical Corporation Extremely low duty-cycle activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
EP2438447B1 (de) * 2009-06-05 2015-02-18 B.R.A.H.M.S GmbH Nachweis von bakteriellen Infektionen bei an Dyspnoe leidenden Patienten.
EP2985352A1 (de) 2009-09-23 2016-02-17 Analytik Jena AG Verfahren zur in vitro erfassung und unterscheidung von pathophysiologischen zuständen
DE102009044085A1 (de) 2009-09-23 2011-11-17 Sirs-Lab Gmbh Verfahren zur in vitro Erfassung und Unterscheidung von pathophysiologischen Zuständen
US9833621B2 (en) 2011-09-23 2017-12-05 Setpoint Medical Corporation Modulation of sirtuins by vagus nerve stimulation
WO2014169145A1 (en) 2013-04-10 2014-10-16 Setpoint Medical Corporation Closed-loop vagus nerve stimulation
AU2010336337B2 (en) 2009-12-23 2016-02-04 Setpoint Medical Corporation Neural stimulation devices and systems for treatment of chronic inflammation
CN102859365B (zh) * 2010-04-15 2016-01-20 洛伊克德克斯有限公司 用于快速确定医学疾病的设备、系统和方法
GB2482187A (en) 2010-07-23 2012-01-25 Univ Exeter Predicting response to surgery
FR2970975B1 (fr) * 2011-01-27 2016-11-04 Biomerieux Sa Procede et kit pour determiner in vitro le statut immunitaire d'un individu
DE102011005235B4 (de) 2011-03-08 2017-05-24 Sirs-Lab Gmbh Verfahren zum Identifizieren einer Teilmenge von Polynucleotiden aus einer dem Humangenom entsprechenden Ausgangsmenge von Polynucleotiden zur in vitro Bestimmung eines Schweregrads der Wirtsantwort eines Patienten
WO2012154865A2 (en) 2011-05-09 2012-11-15 Setpoint Medical Corporation Single-pulse activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
US9216178B2 (en) 2011-11-02 2015-12-22 Biomarin Pharmaceutical Inc. Dry blend formulation of tetrahydrobiopterin
EP2812705B1 (de) 2012-02-07 2016-12-21 Children's Hospital Medical Center Auf mehreren biomarkern basierendes ergebnisrisikostratifizierungsmodell für septischen schock bei erwachsenen
US9238841B2 (en) 2012-02-07 2016-01-19 Children's Hospital Medical Center Multi-biomarker-based outcome risk stratification model for pediatric septic shock
US9572983B2 (en) 2012-03-26 2017-02-21 Setpoint Medical Corporation Devices and methods for modulation of bone erosion
EP2854622A1 (de) 2012-06-05 2015-04-08 Cheetah Medical, Inc. Verfahren und system zur beurteilung der wahrscheinlichkeit von sepsis
EP2882333A1 (de) * 2012-08-09 2015-06-17 Koninklijke Philips N.V. Vorrichtung für die überwachung hämatologischer parameter von patienten
US9953453B2 (en) 2012-11-14 2018-04-24 Lawrence A. Lynn System for converting biologic particle density data into dynamic images
US10354429B2 (en) 2012-11-14 2019-07-16 Lawrence A. Lynn Patient storm tracker and visualization processor
US9759722B2 (en) * 2012-12-17 2017-09-12 Leukodx Ltd. Systems and methods for determining a chemical state
EP3462172B1 (de) 2012-12-17 2023-09-06 Accellix Ltd Systeme und verfahren zum erkennen eines biologischen zustands
US10610861B2 (en) 2012-12-17 2020-04-07 Accellix Ltd. Systems, compositions and methods for detecting a biological condition
US20140170678A1 (en) 2012-12-17 2014-06-19 Leukodx Ltd. Kits, compositions and methods for detecting a biological condition
GB201301611D0 (en) * 2013-01-30 2013-03-13 Shaw Andrew M Systems and methods for medical data processing and analysis
EP2961312A4 (de) 2013-02-28 2017-01-04 Lawrence A. Lynn Patientenüberwachungssystem und visualisierungsprozessor
EP3013985A4 (de) * 2013-06-28 2017-07-19 Acumen Research Laboratories Pte. Ltd. Sepsisbiomarker und verwendungen davon
CN105555800A (zh) * 2013-08-07 2016-05-04 罗切斯特大学 诊断败血症或败血症风险的方法
WO2015077781A1 (en) 2013-11-25 2015-05-28 Children's Hospital Medical Center Temporal pediatric sepsis biomarker risk model
JP6355154B2 (ja) * 2014-04-03 2018-07-11 公益財団法人ヒューマンサイエンス振興財団 診断補助方法
US11311725B2 (en) 2014-10-24 2022-04-26 Setpoint Medical Corporation Systems and methods for stimulating and/or monitoring loci in the brain to treat inflammation and to enhance vagus nerve stimulation
US11406833B2 (en) 2015-02-03 2022-08-09 Setpoint Medical Corporation Apparatus and method for reminding, prompting, or alerting a patient with an implanted stimulator
US10261068B2 (en) 2015-06-04 2019-04-16 Children's Hospital Medical Center Persevere-II: redefining the pediatric sepsis biomarker risk model with septic shock phenotype
US10596367B2 (en) 2016-01-13 2020-03-24 Setpoint Medical Corporation Systems and methods for establishing a nerve block
WO2017127758A1 (en) 2016-01-20 2017-07-27 Setpoint Medical Corporation Implantable microstimulators and inductive charging systems
US11471681B2 (en) 2016-01-20 2022-10-18 Setpoint Medical Corporation Batteryless implantable microstimulators
WO2017127756A1 (en) 2016-01-20 2017-07-27 Setpoint Medical Corporation Control of vagal stimulation
US10583304B2 (en) 2016-01-25 2020-03-10 Setpoint Medical Corporation Implantable neurostimulator having power control and thermal regulation and methods of use
RU2653631C2 (ru) * 2016-10-05 2018-05-11 федеральное государственное бюджетное образовательное учреждение высшего образования "Тюменский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО Тюменский ГМУ Минздрава России) Способ прогноза летальности при гнойно-септических инфекциях в эксперименте
EP3668402A4 (de) 2017-08-14 2021-05-19 Setpoint Medical Corporation Vagusnervstimulationsvorscreening-test
CN109030815B (zh) * 2018-06-26 2021-08-10 安徽医科大学 一种用于检测液相蛋白质交互作用的蛋白质芯片及其制备方法和应用
US11260229B2 (en) 2018-09-25 2022-03-01 The Feinstein Institutes For Medical Research Methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation
WO2020257358A1 (en) * 2019-06-17 2020-12-24 The Broad Institute, Inc. Immune cell signature for bacterial sepsis
KR20230012585A (ko) 2020-05-21 2023-01-26 더 파인스타인 인스티튜츠 포 메디칼 리서치 미주 신경 자극을 위한 시스템들 및 방법들

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1504597A1 (ru) 1986-06-25 1989-08-30 Актюбинский государственный медицинский институт Способ дифференциальной диагностики сепсиса и локализованной гнойной инфекции у новорожденных
EP0406673B1 (de) * 1989-07-01 1995-08-30 Barmag Ag Falschzwirnkräuselmaschine für einen synthetischen Faden
JPH06506195A (ja) 1991-01-14 1994-07-14 ニューヨーク　ユニバシテイ サイトカイン誘導タンパク質、ｔｓｇ−１４、そのためのｄｎａコード化およびその使用
DE4227454C1 (de) 1992-08-19 1994-02-03 Henning Berlin Gmbh Verfahren zur Früherkennung, zur Erkennung des Schweregrads sowie zur therapiebegleitenden Verlaufsbeurteilung einer Sepsis sowie Mittel zur Durchführung des Verfahrens
RU2072103C1 (ru) 1993-06-10 1997-01-20 Ростовский научно-исследовательский институт акушерства и педиатрии Способ диагностики бактериальных инфекций у новорожденных
US5484705A (en) 1994-01-24 1996-01-16 Xoma Corporation Method for quantifying lipopolysaccharide binding protein
US6190872B1 (en) 1994-05-06 2001-02-20 Gus J. Slotman Method for identifying and monitoring patients at risk for systemic inflammatory conditions and apparatus for use in this method
US5804370A (en) * 1994-06-08 1998-09-08 Critichem Medical Products Limited Early diagnosis of sepsis utilizing antigen-antibody interactions amplified by whole blood chemiluminescence
US5566249A (en) * 1994-09-20 1996-10-15 Neopath, Inc. Apparatus for detecting bubbles in coverslip adhesive
US5780237A (en) 1994-10-12 1998-07-14 Cell Therapeutics, Inc. Sepsis, adult respiratory distress syndrome, and systemic inflammatory response syndrome diagnostic
US5830679A (en) 1996-03-01 1998-11-03 New England Medical Center Hospitals, Inc. Diagnostic blood test to identify infants at risk for sepsis
US6077665A (en) * 1996-05-07 2000-06-20 The Board Of Trustees Of The Leland Stanford Junior University Rapid assay for infection in neonates
US6303321B1 (en) 1999-02-11 2001-10-16 North Shore-Long Island Jewish Research Institute Methods for diagnosing sepsis
JP4777580B2 (ja) * 2000-03-28 2011-09-21 トラスティーズ・オブ・ダートマウス・カレッジ 炎症および炎症状態の検出方法
US7465555B2 (en) * 2002-04-02 2008-12-16 Becton, Dickinson And Company Early detection of sepsis

Also Published As

Publication number Publication date
WO2003084388A3 (en) 2004-08-12
EP1490789A4 (de) 2006-08-30
JP2005521882A (ja) 2005-07-21
JP4520157B2 (ja) 2010-08-04
EP1490789B1 (de) 2009-09-23
EP1490789A2 (de) 2004-12-29
WO2003084388A2 (en) 2003-10-16
DE60329377D1 (de) 2009-11-05
US7465555B2 (en) 2008-12-16
US20030194752A1 (en) 2003-10-16

Similar Documents

Publication Publication Date Title
ATE443867T1 (de) Methode zur vorhersage der sepsis in einem patienten mit systemischem inflammatorischem response-syndrom (sirs)
TW200616578A (en) Fluid handling devices
WO2007126444A3 (en) Analyte monitoring
WO2007041245A3 (en) Biomarkers for multiple sclerosis and methods of use thereof
ATE539675T1 (de) System und verfahren zur bestimmung einer analytenkonzentration mit einer hämatokrit- korrektur
WO2005048823A3 (en) Modeling of systemic inflammatory response to infection
DE602005022704D1 (de) Sensor für mehrere analyte
WO2008070137A3 (en) Interferon alpha-induced pharmacodynamic markers
FI20041323A (fi) Analysoija, järjestelmä ja menetelmä toivotun käyttäjäjoukon määrittämiseksi
ATE459883T1 (de) Neue proliferationsmarker in der klinischen praxis und deren verwendung zur krebsprognose oder -diagnose
BRPI0307697A2 (pt) método para o monitoramento, estimativa e construção de equações para estimação da concentração de um analito selecionado dentro de uma amostra, método para a determinação do volume de uma amostra e de um conjunto de fatores ambientais presentes em um sistema eletroquímico, aparelho e método para a determinação da identidade de uma amostra em contato eletrolítico com um sistema eletroquímico
WO2005081867A3 (en) Salivary mrna profiling, biomarkers, and related methods and kits of parts
JP2010506147A5 (de)
ATE493645T1 (de) Elektrochemischer sensor zur ermittlung einer analyt-konzentration
ATE557101T1 (de) Verfahren und zusammensetzungen zur bestimmung eines transplantationstoleranten phänotyps in einem individuum
NZ551782A (en) Agents and methods for diagnosing stress
CA2510377A1 (en) Use of nicotinamide n-methyltransferase as a marker for colorectal cancer
NO20081343L (no) Biosensor-måleanordning, biosensor-målesystem og biosensor-målemetode
WO2009141352A3 (en) Risk analysis in patients with and without metabolic syndrome
DE602006015221D1 (de) Verfahren zur diagnose von sepsis durch analyse von cytokine mrna expression
BRPI0512655A (pt) bioexame de rna
DE60323677D1 (de) Verfahren zur bestimmung des wiederauftretens von prostata krebs
DE602004029156D1 (de) Prognose des verlaufs einer krebserkrankung
DK1687636T3 (da) Hurtig bestemmelse af forskellige former for hepatocytvækstfaktor (HGF) i legemsvæsker
ATE537455T1 (de) Monoklonale und polyklonale antikörper gegen huftier-albumin und -hämoglobin sowie vorrichtung und verfahren unter verwendung der antikörper bei der erkennung und findung von geschwüren und anderen verdauungsbedingten krankheiten und blutungen bei huftieren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties